HomeFATE • NASDAQ
add
Fate Therapeutics Inc
Previous close
$3.87
Day range
$3.74 - $3.95
Year range
$1.63 - $8.83
Market cap
429.77M USD
Avg Volume
2.59M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.68M | -96.22% |
Operating expense | 15.94M | -26.17% |
Net income | -44.12M | 21.72% |
Net profit margin | -2.63K | -1,971.76% |
Earnings per share | -0.45 | 22.41% |
EBITDA | -30.29M | 49.16% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 315.18M | -27.75% |
Total assets | 506.22M | -28.25% |
Total liabilities | 137.80M | -37.82% |
Total equity | 368.42M | — |
Shares outstanding | 99.24M | — |
Price to book | 1.03 | — |
Return on assets | -16.75% | — |
Return on capital | -17.95% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -44.12M | 21.72% |
Cash from operations | -36.64M | 51.40% |
Cash from investing | 45.35M | -14.61% |
Cash from financing | -180.00K | -111.87% |
Net change in cash | 8.54M | 141.12% |
Free cash flow | -12.17M | 74.10% |
About
Founded
2007
Website
Employees
181